Skip to content
Medical Health Aged Care

Nurses and midwives showcase innovative healthcare solutions

The Australian Nursing and Midwifery Federation (ANMF) < 1 min read

The Australian Nursing and Midwifery Federation (ANMF) will join nursing and midwifery leaders from across the country at Parliament House today (Tuesday 30 June), for a ‘hands on’ demonstration of the high-quality, clinical capabilities of Australia's largest health workforce.

The Parliamentary Friends of Nursing event in the Mural Hall, will highlight the growing role of nurses and midwives in delivering timely, effective health care across the community, enabling people to access high-quality care, when and where they need it.

ANMF Federal Secretary Annie Butler said the event will demonstrate nurse and midwife-led models of care that demonstrate the impact they can have on health outcomes when nurses and midwives work to their full scope of practice.

“Nurses and midwives are at the frontline of healthcare and are uniquely placed to identify community needs and deliver innovative, person-centred solutions," Ms Butler said.

“That’s why today’s event gives us the opportunity to showcase the breadth of skills, knowledge and expertise that nurses and midwives have and the important role they play in improving outcomes across the health and aged care sectors.”

The event will feature a series of live demonstrations and exhibits, including advanced assessment and injury management skills, street healthcare services, remote care technology, aged care innovations and regional and remote healthcare models, such as the Women's Health Mobile Clinic.

The Clinic’s nurses are helping close the gap in healthcare access for women and adolescents across rural and regional Victoria, providing sexual and reproductive health and general well-being care as well as cervical and bowel screenings.

"Australia's health and aged care challenges require innovative, new models of care - and nurses and midwives must be part of the solution,” Ms Butler explained.


About us:

The ANMF, with over 356,000 members, is the industrial and professional voice for nurses, midwives and carers in Australia. 

ANMF media release authorised by Annie Butler, ANMF Federal Secretary. 1/365 Queen St, Melbourne. 


Contact details:

ANMF media inquiries:

Richard Lenarduzzi 0411 254 390

More from this category

  • Medical Health Aged Care
  • 30/06/2026
  • 00:33
Medisca

Medisca Enters Its Next Chapter Under Founder Antonio Dos Santos

Medisca today announced that Founder and Chairman Antonio Dos Santos has returned to the role of Chief Executive Officer as the company enters its…

  • Contains:
  • Medical Health Aged Care
  • 29/06/2026
  • 23:17
Optimi Health Corp.

Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression

Optimi’s 5mg psilocybin capsules are prescribed in Australia for treatment-resistant depression.The export marks Optimi’s third commercial shipment since launching the 5mg psilocybin capsules in September 2025.VANCOUVER, British Columbia, June 29, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the “Company” or “Optimi”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced the completion of its latest export of 5mg psilocybin finished drug product to Australia, marking its third commercial shipment since the September 2025 launch of its 5mg psilocybin capsules.The shipment included 1,000 capsules of 5mg psilocybin, which are being prescribed in Australia…

  • Medical Health Aged Care
  • 29/06/2026
  • 22:47
Kyowa Kirin

New PROSPER Data Demonstrate Real-World Impact of Mogamulizumab on Symptoms and Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome

Clinically meaningful improvements in skin symptoms reported as early as week 4 and sustained over the 48-week study period Data presented at the 6th World Congress of Cutaneous Lymphomas meeting in Montreal, CanadaPRINCETON, N.J., June 29, 2026 (GLOBE NEWSWIRE) -- Kyowa Kirin, Inc., a wholly owned subsidiary of Kyowa Kirin Co. Ltd (TSE: 4151), today announced positive results from PROSPER, a real-world observational study of mogamulizumab in adults with mycosis fungoides (MF) or Sézary syndrome (SS). In the study, patients reported clinically meaningful improvements in skin symptoms (itch, flaking, and redness) and body temperature regulation as early as week 4, with…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.